H2 TEXT FOR SEARCH ENGINES
Other advanced cardiovascular risk tests
Cardiovascular disease is complex. To enable healthcare providers to evaluate any underlying disorders (diabetes and altered kidney, liver and thyroid function) or side effects of lipid-altering medications (liver enzymes, creatine phosphokinase, glycosylated hemoglobin and uric acid), we offer a number of other tests.
These include, but are not limited to:
- Lipid, lipoprotein, and apolipoprotein tests: direct HDL-C, apoA-I, apoA-I in HDL subclasses, LDL-C, small dense LDL-C, apoB and Lp(a)
- Metabolic tests: hemoglobin A1c (HbA1c), insulin resistance (HOMA-IR), glucose, insulin, adiponectin and glycated serum protein (GSP)
- Inflammation tests: myeloperoxidase (MPO), high sensitivity C-reactive protein (hs-CRP), lipoprotein associated-phospholipase A2(LpPLA2) and fibrinogen
- Genetic tests: Boston Heart Statin Induced Myopathy (SLCO1B1) Genotype, apoE Genotype, Clopidogrel Response (CYP2C19) Genotype, Factor V Leiden Genotype, Factor II Genotype and MTHFR Genotype
- Liver, kidney, muscle and other tests:
- Liver: alkaline phosphatase, alanine aminotransferase (ALT), aspartate amino transferase (AST)
- Kidney: blood urea nitrogen (BUN), creatinine, BUN/Creatinine, estimated glomerular filtration rate (eGFR)
- Muscle: creatine kinase (CK), homocysteine, N-terminal pro-brain natriuretic peptide (NT-proBNP), uric acid
- Thyroid: Total T4, Free T4, Total T3, Free T3, thyroid-stimulating hormone (TSH)
- Other: albumin and 25-OH vitamin D
For a complete directory of our tests please visit the test menu.